Neopterin (semm. urine) and other markers of macrophage activation (lL-L IL-6, TNF alpha) were compared in preeclamptic patients and healthy pregnant controls. The prepartal urine neopterin median in preeclampsia (337 Ilmol/mol creat.) was 33% higher than that of healthy pregnant controls (253 Ilmol/mol creaL). There was no statistic!llly significant difference between the groups (p = 0.08). In plasma there were no statistically significant differences in cytokine concentrations between healthy pregnant and nonpregnant controls with the exception of neopterin. that showed higher values in pregnant women (p = O.OO4). Elevated levels of IL-6. TNF-alpha and neopterin were observed in hypertensive women. Differences to healthy pregnant control s were statistically significant for IL-6 (p = 0.(08). TNF-alpha (p = OJ)09) and neopterin (p=O. 04) a nd were more pronounced in severe forms of th e disease. These three parameters of monocytic origin showed positive significant correlations amongst each other. A participation of macrophages in the pathomechanism of hypertensive disorders of pregnancy can thus be assumed.
Introduction
In recent years. immunological factors have been increasingly di scussed as the cause of hypertensive disorders of pregnancy (l). An inadequate reaction of the maternal immune system to fetal antigens might be responsible here (2) and induce the absence of the adaptive dilatation of the spiral arteries causing thrombocyte activation (3). In the pathomechanism of preeclampsia immunocompetent white blood cells arc involved. too (4) . Relatively little is known about the behavior of macrophages in thesc hypertensive di seases (4) . The total number of peripheral monocytes is increased in late pregnancy (5) . Neopterin (in semm and urine) as a marker of macrophage activation is significantly highcr in healthy pregnant women compared with nonpregnant control s (6) .
The purpose of our study was to examine: l. The behavior of urine neopterin in patients § Author to whom correspondence should be addressed.
Ptl!ri dines ! Vol. 4 ! No.3 with hypertensive disorders of pregnancy compared with healthy pregnant controls. 2. The behavior of plasma factors of macrophage activation namely interleukin I (IL-I), interleukin 6 (lL-6). tumor necrosis factor alpha (TN F) and neopterin in patients with hypertensive disorders of pregnancy in comparison to healthy pregnant and nonpregnant controls.
Materials and Methods
Urine neopterin was analysed in 22 severe preeclamptic patients (including 14 with HELLP syndrome) and 20 healthy pregnant controls (matched for age and gestational age) before deliveIY and on eac h of the five postpartum days. Neopterin was measured by high performance liquid chromatography. Relating urine neopterin to urine creatinine concentration in spot urine samples, it was possible to neglect physiological variations of urine density.
Markers of macrophage activation (lL-l. IL-6. TNF-alpha. neopterin) in plasma were analysed in 37 patients with hypertensive disorders of pregnancy (28th to 40th week). As classified by the International Society for the Study of Hypertension in Pregnancy. five patients suffered from pregnancy-induced hypertension. 20 from preeclampsia. ten from HE-LLP-syndrome and two from eclampsia.
The control group consisted of ten healthy pregnant women (37th to 39th week) and ten healthy nonpregnant women (all age-matched).
]n all 20 controls the laboratory values (hemoglobin. leukocytes. thrombocytes. serum glutamic oxaloacetic transaminase. lactic dehydrogenase. creatinine. blood sedimentation rate. urine). measured to rule out any other general illnesses. had to be in the normal range.
Heparinized blood samples from all patients were centrifuged immediately after being taken and frozen until processing. Cytok;nes were measured by radioimmunoassay (IL-1. IL-6. TNF-alpha: all Medgenix Diagnostics. Fleurus. Belgium; neopterin: Henning. Berlin. Germany).
Group comparisons for continuous variables were performed by Mann-Whitney U test. Correlations between variables were expressed in the Spearman rank correlation coefficient (rs).
Results
Prepartal unne neopterin medians in preeclampSia (337 /lmol/mol creat.; interquartile 256-458 /lmol/mol creat.) were 33% higher than those of healthy pregnant controls (253 /lmol/mol creat.; interquartile 174-317 /lmol/mol creat.) (Fig. 1) . Because of the widespread range of neopterin values in both groups only a trend. but no statistically significant difference could be achieved by Mann-Whitney U test (p = 0.08).
Concommitant with clinical improvement of preeclamptic patients (resolution of thrombocytopenia. decreasing blood pressure) neopterin medians became indistinguishable from those of the control group. From day 3 postpartum values largely corresponded (Fig. 2) .
Macrophage activation was also examined in plasma by determination of IL-I. IL-6. TNF-alpha and neopterin (Table I) :
In all groups IL-I showed medians below the exact detection limit (5 pg/ml). There were no statistically significant differences between the groups.
Quite different were out observations in IL-6: In both control groups and in parients with pregnancy- Urine oeopterin (IJmol / mol creat.) induced hypertension all IL-6 values were below the detection limit of 3 pg/ml. Women with proteinuric hypertension demonstrated values above 3 pg/ml in 18 of 32 cases (56%). Statistically significant differences between healthy pregnant controls and patients with preeclampsia (p = 0.02). patients with HELLP syndrome (p = 0.(01) and all hypertensive women (p=0.OO8) were noted here. The same differences were observed between the nonpregnant controls and the hypertensive patients. Women with HELLP syndrome also differed with a statistical significance from those with pregnancy-induced hypertension (p=O.OI) and those with preeclampsia (p=0.02). TNF-alpha medians of both control groups largely corresponded and were exceeded by those of hypertensive women (Table I) . Healthy pregnant women differed from hypertensive patients (p=O.009) and from those with HELLP syndrome respectively (p= O'()()()3). The diflerences between nonpregnant controls and hypertensive women were significant. too (p = fl.O(2).
Neopterin demonstrated higher values in healthy pregnant than in healthy nonpregnant women (p= 0.004). Hypertensive patients only showed a moderate increase of neopterin values compared to healthy pregnant controls (p = fl.(4). The highest levels could be found in patients with HELLP syndrome and eclampsia (p = 0.007). Nonpregnant controls and hypertensive women ditfered with a high significance (p=O.OOOI). Also patients with preeclampsia and HELLP syndrome differed significantly (p=(l.()2).
In hypertensive women significant positive correlations were found between neopterin and TNF-alpha (rs=0.6\: p<O.OOI). neopterin and IL-6 (rs=0.61; p<0.OOI)JL-6 and TNF-alpha (r5=0.38; p=O.OI) and neopterin and IL-I (rs=0.32; p=O.03).
Discussion
From our results in urine neopterin. that showed at 33% higher levels in preeclampsia. we assume a moderate activation of macrophages in the pathomechanism of hypertensive disorders of pregnancy. As all our neopterin values were related to Uline creatinine as a neopterin/creatinine ratio. the intlucncc of renal impaimlent could be minimized. These results were continned by our findings in plasma demonstrating similar eI.evations of neopterin in preeclamptic patients. more pronounced in those with HELLP syndrome. Comparing serum parameters. which are excreted by the kidney. it is necessary to account for renal impairment, because in this condition serum creatinine and neopterin levels are increased. Therefore it must he mentioned that serum creatinine concentrations of all hypertensive women were below 1.0 mgld!. The relatively good renal condition of our HELLP patients is caused by our laboratory screening programm in hypertensive women. containing hemoglobin. thrombocytes. serum oxaloacetic and pyruvic transaminase. serum and urinary protein. colloid osmotic pressure. creatinine. uric acid and the hemolysis markers hilirubin. lactic dehydrogenase and haptoglohin (7. X). With this laboratory program an incipient HELLP syndrome could be diagnosed I to 2 days before the complete clinical picture became apparent. Giving the possibility of timely application of the sensitive hemolysis markers. the high rate of fetal mortality and matemal complications (in most cases a mUltiple organ dysfunction) was reduced drastically in our department by early termination of pregnancy.
Also the significant con-elations hetween neopterin. IL-6 and TNF-alpha express. that macrophages participate in the pathomechanism of preeclampsia. It must be mentioned. that the activation of macrophages can he influenced by the altered prostaglandin balance. On the other hand stimulation of the platelet activating f~\Ctor by monocytic cytokines resulting in a thrombocyte activation could calise the prostacyelin/ thromhoxane imhalance (9) . Monocytic cytokines can modulate and induce endothelial antigens in vitro (10. II) . that bind endothelial cell antihodies (12) .
At least an increased production of the vasoconstrictor endothelin. that is elevated in preeclampsia. was experimentally found in amnion stimulatcd by TNF-alpha or IL-6 (13. 14).
It has even been suggested. that changes of ptelidine metabolism may directly cause eleva ted blood pressure. and may be involved in the pathogenesis of the HELLP syndrome (IS). In f~lct. letrahydrobiopterin is a coenzyme for nitlic oxide (NO) sy nthase. which converts L-arginine to L-citrulline and NO (16) . NO. being an important vasodilator. was earlier denominated as endothelial derived rel ax ing factor (EDRF). We found elevated neopterin leve ls in healthy pregnant women as well as in the preeclamptic and HELLP patients. But no significant changes of biopterin concentrations in serum have heen ohselvcd in earlier studies. Biopterin levels tended even to increasc rather than to decrease during normal pregnancy (17) . From this d a ta one may expect that sufficient amounts of tetrah ydrobiopterin should hc available during prcgnancy. therefore also hiosynthesis of NO should be normal. HO\\c\cr. blood 1e-\'cIs do not necessa ril y reflcct thc situation in cells. and there remain s the poss ibility that hiopterin Ic\els hehave differently in hypertensive disorders of pregnancy compared to normal pregnancy. although to date no evidence is availahli: to supp0l1 this conclusion. In contrast. large amounts of neopterin arc released by human monocytes/ macrophagcs upon stimulation with interfCron gamma in vitro. Higher concentrations or neopterin in hypertensive disorders of pregnancy may indicate increased endogenous t(mnation of interfCro n gamma. which a lso may lead to an increase of hiopterin levels. A variety of human cells respond to stimulation with interferon gamma with activation of GTP-cyclo hydrolase 1. Only monocytes/ macrophages respond with an excess production of neoptelin compared to hiopterin . whereas other cells like endothelial cells produce approximately IO-fold high er concentrations of biopterin. which can he detected intracellularly and in th e supernatants o f cells (18) . One may expect even a ri se of tetrahydrohiopterin in these cells eatalizing the formation of NO. But agai n. the in I'ivo situation could he ditTcrcnt. since even in clinical situations associated with extremely high levels of neopterin. slIch as cytomegalovirus infection. only a moderate or no increase of bioptcrin was observed (19).
